Clinical Trials on Norovirus, Prevention in Sweden

Total 35 results

Lund University
Anti-Diabetic Food Centre

Completed

Effects of Legumes on Glucose Regulation

Dietary Prevention

Sweden
Sophiahemmet University
Karolinska Institutet; Dalarna University

Recruiting

Development and Evaluation of Somali-adapted Mindfetalness

Prevention

Sweden
Umeå University
Ministry of Health and Social Affairs, Sweden

Completed

Preventive Home Visits for Healthy Pensioners- a Randomized Controlled Trial

Prevention | House Calls

Sweden
Karolinska Institutet

Not yet recruiting

"Stay Balanced" - Prevention of Falls in Older Adults - From Clinical Research to Clinical Practice

Prevention Harmful Effects

Sweden
Gunilla Fahlstrom
Örebro County Council; Örebro University, Sweden

Completed

Fall Prevention Among Community Living Elderly

Accidental Falls/Prevention and Control

Sweden
Uppsala University
Uppsala Tjej- och Transjour

Enrolling by invitation

Adolescent Consent & Sexual Violence: A School Intervention Evaluation

Violence Prevention Intervention Evaluation Among Youth

Sweden
Lund University

Completed

Prebiotic Effects on Glucose Tolerance

Diet Prevention of Metabolic Diseases

Sweden
Swedish University of Agricultural Sciences
Good Food Practice, Sweden; Lantmannen Research and Development

Unknown

Effect of Three Weeks Consumption of Rye Porridge Breakfast

Obesity Prevention

Sweden
Karolinska Institutet
Swedish Council for Working Life and Social Research; The Kamprad Family Foundation...

Completed

The Healthy School Start Plus Intervention Study

Physical Activity | Parent-Child Relations | Dietary Habits | Overweight and Obesity | Prevention

Sweden
Valentina Hlebec
LINNEUNIVERSITETET (LNU), Sweden (leading the consortium); EUROCARERS-ASSOCIATION... and other collaborators

Completed

A Primary Prevention Intervention for the Promotion of Psycho-social Wellbeing in Adolescent Young Carers: (ME-WE)

Mental Health Wellness 1 | Primary Prevention | Cognitive Therapy | Caregivers | Adolescent - Emotional Problem

Slovenia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
Probi AB

Completed

Efficacy of Probiotics on Iron Status During Pregnancy

Prevention of Iron Deficiency

Sweden
Genzyme, a Sanofi Company

Terminated

Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

Adhesion Prevention (Abdominal)

France, Sweden
Diamyd Medical AB

Recruiting

Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes

Autoimmune Diseases | Diabetes Mellitus, Type 1 | Prevention

Sweden
Region Skane
Lund University; Vinnova; Innovation Skåne AB/ Sweden

Completed

Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Urinary Catheters

Anesthesia, Local | Incontinence, Urinary | Urinary Catheters | Retention, Urinary

Sweden
Oslo University Hospital

Recruiting

Study of Antithrombotic Treatment After IntraCerebral Haemorrhage (STATICH)

Atrial Fibrillation | Intracranial Hemorrhages | Cerebral Hemorrhage | Secondary Prevention | Anticoagulant-Induced Bleeding

Norway, Denmark, Sweden
Rigshospitalet, Denmark
Abbott; Feops

Unknown

Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure

Atrial Fibrillation | Stroke Prevention

Denmark, Spain, Sweden, Belgium, Canada, France, Italy
Bayer

Completed

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial (ODiXaHip)

Thromboembolism | Prevention

Belgium, Denmark, Austria, Germany, Netherlands, Poland, Sweden, Israel, France, Norway, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Germany, United Kingdom, France, Italy, United States, Hungary, Norway, Spain, Argentina, Brazil, Poland, Sweden, Turkey
AstraZeneca

Terminated

Long Term Open Follow-up With H376/95 vs. Warfarin

Stroke Prevention in Patients With Atrial Fibrillation

Sweden, Norway, Poland, United Kingdom, Finland, Denmark, United States, Czech Republic, Belgium
Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Respiratory Syncytial Virus Infection Prevention

Germany, Spain, Belgium, Sweden, United States
Swedish Orphan Biovitrum

Terminated

Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants (LAIF)

Prevention of Growth Restriction

Belgium, France, Germany, Hungary, Italy, Poland, Spain, Sweden, Czech Republic, Russian Federation
Bayer

Completed

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (RECORD 2)

Venous Thromboembolism | Prevention

Denmark, Italy, China, Indonesia, Colombia, Portugal, United States, Australia, Korea, Republic of, Taiwan, Canada, Estonia, New Zealand, Brazil, Mexico, South Africa, Peru, United Kingdom, Latvia, India, Lithuania, Sweden, Norway
Boehringer Ingelheim

Completed

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Arthroplasty, Replacement | Prevention of Venous Thromboembolism | Moderate Renal Impairment (CrCl 30-50 mL/Min)

Austria, Canada, Czechia, Finland, Netherlands, Sweden
Bayer

Completed

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. (RECORD 3)

Venous Thromboembolism | Prevention

Belgium, Italy, Poland, Spain, China, France, Denmark, Netherlands, Austria, Germany, Mexico, South Africa, Sweden, Colombia, Israel, Canada, Norway, Peru, Czech Republic
Örebro University, Sweden
Karolinska Institutet; Linkoeping University

Active, not recruiting

Onset PrevenTIon of Urinary Retention in Orthopaedic Nursing and Rehabilitation (OPTION)

Hip Fractures | Urinary Retention | Hip Arthritis

Sweden
Boehringer Ingelheim

Completed

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Venous Thromboembolism | Secondary Prevention

United States, Norway, Canada, Belgium, Thailand, Italy, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, France, Lithuania, Mexico, Russian Federation, Sweden, Switzerland, Ukraine
Amgen

Completed

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

Treatment for Prevention of Chronic Migraine

United States, United Kingdom, Poland, Germany, Czechia, Sweden, Canada, Denmark, Finland, Norway
Amgen

Completed

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Treatment for Prevention of Chronic Migraine

United States, United Kingdom, Poland, Germany, Czechia, Sweden, Canada, Denmark, Finland, Norway
Bayer
Janssen Research & Development, LLC; Population Health Research Institute

Completed

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

Prevention & Control

Belgium, Finland, France, China, United States, Colombia, Ireland, Philippines, Japan, Hungary, Canada, Germany, Australia, Chile, Czechia, Korea, Republic of, Malaysia, Brazil, Denmark, Israel, Russian Federation, South Africa, Ecu... and more
Novartis Pharmaceuticals

Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Primary Prevention of Atherosclerotic Cardiovascular Disease

United States, China, Italy, Spain, France, Netherlands, Poland, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Malaysia, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South... and more
Boehringer Ingelheim

Completed

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Stroke | Secondary Prevention

Korea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
Sanofi

Completed

Clinical Trial in Males With BPH (Enlarged Prostate)

Prostatic Hyperplasia | Urinary Retention | Benign Prostatic Hypertrophy

United States, Canada, Poland, Romania, Australia, Netherlands, Portugal, Spain, Sweden, Bulgaria, Denmark, Finland, Hungary, Norway, South Africa, Greece, Israel
Bayer

Terminated

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke (OCEANIC-AF)

Atrial Fibrillation | Prevention of Stroke or Systemic Embolism

Canada, United States, Israel, Korea, Republic of, China, Taiwan, Belgium, Australia, Singapore, Malaysia, Slovakia, United Kingdom, Czechia, Latvia, Japan, Brazil, Lithuania, Germany, France, Sweden, Turkey, Switzerland, Estonia, Bul... and more
Janssen Research & Development, LLC

Recruiting

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

United States, United Kingdom, Korea, Republic of, Taiwan, Canada, Denmark, France, Thailand, New Zealand, Spain, China, Israel, Germany, Colombia, India, Netherlands, Australia, Japan, Sweden, Czechia, Italy
Bayer

Recruiting

A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke (OCEANIC-STROKE)

Acute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic Attack

United States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more

Clinical Trials on Norovirus, Prevention in Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations